BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16419471)

  • 1. [Subtotal transurethral prostatectomy in the treatment of patients with prostatic cancer].
    Mazo EB; Chepurov AK; Zoria OV
    Urologiia; 2005; (6):6-10. PubMed ID: 16419471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experiences with intensive radiotherapy of prostatic cancer in conjunction with surgery (transurethral resection, pelvic lymph node excision)].
    Oehler W; Ranft R; Lessel A; Merkle K; Fischer J
    Z Urol Nephrol; 1989 Dec; 82(12):645-52. PubMed ID: 2629419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of transurethral resection in cancer of the prostate].
    Rodríguez JV; Chechile G
    Arch Esp Urol; 1989; 42 Suppl 2():165-77. PubMed ID: 2639620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [One-stage transurethral resection of the urinary bladder and the prostate in patients with superficial cancer of the urinary bladder combined with benign prostatic hyperplasia].
    Karaguzhin SG; Merinov DS; Martov AG
    Urologiia; 2005; (5):17-21. PubMed ID: 16281833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
    Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostate cancer after prostatectomy for benign prostatic hyperplasia].
    Hua L; Zhang J; Wu H; Sui Y; Zhang W; Qian L; Wang Z
    Zhonghua Nan Ke Xue; 2004 Aug; 10(8):612-3. PubMed ID: 15362527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advancement of treatment for prostate cancer].
    Hara I
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):178-82. PubMed ID: 16484852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pro and contra -- adjuvant therapy in locoregional advanced prostatic carcinoma after radical prostatectomy].
    Ohlmann C; Heidenreich A
    Aktuelle Urol; 2004 Sep; 35(5):372-4. PubMed ID: 15478268
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcome after radical prostatectomy in young men with or without a family history of prostate cancer.
    Rouprêt M; Fromont G; Bitker MO; Gattegno B; Vallancien G; Cussenot O
    Urology; 2006 May; 67(5):1028-32. PubMed ID: 16698363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ preservation in the management of bladder and prostate cancer.
    Vitale V
    Rays; 1997; 22(3):406-9. PubMed ID: 9446944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fluorescent cystoscopy and transurethral electroresection in diagnosis and treatment of patients with invasive cancer of the urinary bladder].
    Komiakov BK; Gorelov SI; Novikov AI; Gorelov AI; Novikov PB; Strokova LA; Al-Atar T
    Urologiia; 2004; (6):37-40. PubMed ID: 15719729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing prostate specific antigen following radical prostatectomy and adjuvant hormonal therapy: doubling time predicts survival.
    Sengupta S; Blute ML; Bagniewski SM; Myers RP; Bergstralh EJ; Leibovich BC; Zincke H
    J Urol; 2006 May; 175(5):1684-90; discussion 1690. PubMed ID: 16600730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled study.
    Ozdal OL; Ozden C; Benli K; Gökkaya S; Bulut S; Memiş A
    Prostate Cancer Prostatic Dis; 2005; 8(3):215-8. PubMed ID: 15999118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
    Nelson BA; Shappell SB; Chang SS; Wells N; Farnham SB; Smith JA; Cookson MS
    BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined use of TUVP and TURP for prostate cancer with bladder outlet obstruction].
    Yang GT; Yao MY; Yang JJ; Yuan Z; Liu J; Huo MD; Zhang XW
    Zhonghua Nan Ke Xue; 2005 Jul; 11(7):523-5. PubMed ID: 16078672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of incidental prostate cancer following TUPVP (a report of 15 cases)].
    Gu X; Zhu Q; Zhang P; Zhang Y; Lu Z; Xu Y; Huang S
    Zhonghua Nan Ke Xue; 2004 Nov; 10(11):849-50, 854. PubMed ID: 15595689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of blood transfusion on survival after radiotherapy as treatment for carcinoma of the prostate.
    Davies AH; Ramarakha P; Cranston D; Clarke PJ
    Ann R Coll Surg Engl; 1991 Mar; 73(2):116-8. PubMed ID: 2018314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radical therapy for prostate cancer in Norway].
    Johansen TE
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1658-60. PubMed ID: 15976834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized prostate carcinoma treated with TUR and neodymium-YAG laser irradiation.
    Beisland HO; Sander S
    Scand J Urol Nephrol Suppl; 1991; 138():117-9. PubMed ID: 1784994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.